Masato Kato

Title: Masato Kato: Innovator in Synthetic Constructs

Introduction

Masato Kato is a notable inventor based in Hawthorne, Australia. He has made significant contributions to the field of synthetic constructs, particularly in the area of proteoglycans. With a total of 4 patents to his name, Kato's work has implications in various biological and medical applications.

Latest Patents

Kato's latest patents focus on the construction and use of synthetic constructs encoding syndecan, a purified mammalian proteoglycan. These patents detail genetic information encoding such proteoglycans, which have a core polypeptide molecular weight of about 30 kD to about 35 kD. The constructs include a hydrophilic amino terminal extracellular region, a hydrophilic carboxy terminal cytoplasmic region, and a transmembrane hydrophobic region. Additionally, they feature a protease-susceptible cleavage sequence and at least one glycosylation site for the attachment of a heparan sulfate chain. The glycosylation site is represented by a specific formula, which includes an amino acid residue with an acidic sidechain.

Career Highlights

Throughout his career, Kato has worked with reputable organizations, including Children's Medical Center Corporation and Leland Stanford Junior University. His experience in these institutions has allowed him to collaborate with leading experts in the field.

Collaborations

Some of Kato's notable coworkers include Scott Saunders and Merton Bernfield. Their collaborative efforts have contributed to advancements in the understanding and application of proteoglycans.

Conclusion

Masato Kato's innovative work in synthetic constructs and proteoglycans showcases his dedication to advancing scientific knowledge. His patents reflect a commitment to improving medical and biological applications through research and collaboration.